ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: SA-PO594

Heme Oxigenase-1 (HO-1) and Inducible Nitric Oxide Synthase (iNOS) Modulate by Resveratrol in Contrast-Induced AKI in CKD Rats

Session Information

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms


  • Fernandes, Sheila Marques, Universidade de São Paulo (USP), São Paulo, São Paulo, Brazil
  • Vattimo, Maria De Fatima, Universidade de São Paulo (USP), São Paulo, São Paulo, Brazil
  • Watanabe, Mirian, University of Sao Paulo, Sao Paulo, Brazil
  • Peres, Karina Batista, EEUSP, São Paulo, Brazil
  • Martins, Daniel Malisani, University of São Paulo, Carapicuíba, Brazil
  • Vasco, Carolina Ferreira, Universidade de São Paulo, São Paulo, Brazil

Group or Team Name

  • Experimental lab on animal models

Iodinated contrast (IC)-induced acute kidney injury (AKI) is an important complication in patients with chronic kidney disease (CKD). In previous studies, we demonstrated a protective effect of Resveratrol (R) treatment demonstrated improvement of renal function in IC-AKI by renal hemodynamic modulation in CKD rats (VATTIMO MFF, JASN 2016). The aim of this study was to evaluate the potential renoprotective effect of resveratrol as anti-oxidate and anti-nitrosative by modulation of heme oxygenase-1 (HO-1) and nitric oxide induced synostosis (iNOS) in rats with CKD treated with IC.


Wistar, adult, male rats were randomized in four groups. Sham (control group), 5/6 (CKD model: 5/6 nefrectomy), 5/6+IC (CKD model + IC, 6ml/Kg, intraperitoneal- i.p., single dose), 5/6+IC+R (CKD model + R, 25 mg/Kg, intraperitoneal, single dose + IC, i.p, single dose, 30 minutes after R). Gene expression and protein syntesis of HO-1 and iNOS in renal tissue were evaluated.


Treatment with IC significantly incresed gene expression and protein synthesis of HO-1 in 5/6 + IC rats compared to the 5/6 (DRC model) group and treatment with Resveratrol induced an additional elevation in gene expression and in the protein synthesis of HO-1 in 5/6 + IC + R rats. The levels of gene expression and protein synthesis of iNOS also to increase in the kidney of 5/6+IC group. 5/6 + IC + R reduced iNOS protein levels compared to 5/6 + IC rats.


These results demonstrate that Resveratrol influence renal HO-1 and iNOS expression after IC-induced AKI in CKD rats and may contribute to better outcomes in this setting by involvement in the modulation of oxidative and nitrosative stress.


  • Government Support - Non-U.S.